Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Sep;84(9):1337-45.
doi: 10.1902/jop.2012.120422. Epub 2012 Nov 23.

Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to Porphyromonas gingivalis

Affiliations
Comparative Study

Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to Porphyromonas gingivalis

Ezel Berker et al. J Periodontol. 2013 Sep.

Abstract

Background: Chronic periodontitis (CP) is an inflammatory disease in which cytokines play a major role in the progression of disease. Anti-inflammatory cytokines (interleukin 4 [IL-4] and IL-10) were reported to be absent or reduced in diseased periodontal tissues, suggesting an imbalance between the proinflammatory and anti-inflammatory mediators. This study tests the hypothesis that there is cellular crosstalk mediated by proinflammatory and anti-inflammatory cytokines and that blocking proinflammatory cytokine (tumor necrosis factor-α [TNF-α] and IL-1) production will enhance anti-inflammatory cytokine (IL-4 and IL-10) production from peripheral blood mononuclear cells (PBMCs) in response to Porphyromonas gingivalis.

Methods: PBMCs were isolated from individuals diagnosed with CP or healthy individuals and cultured for 24 hours. Concanavalin A (ConA) was used as an activator of lymphocyte function. Live and heat-killed P. gingivalis or lipopolysaccharide from P. gingivalis were used as the bacterial stimulants. TNF-α and IL-1 production was neutralized by specific antibodies against TNF-α and IL-1α or IL-β. Culture supernatants were evaluated by enzyme-linked immunosorbent assay for TNF-α, IL-1β, IL-4, and IL-10 production.

Results: Live P. gingivalis did not result in any significant IL-10 or IL-4 release, whereas heat-killed P. gingivalis led to a significant increase in IL-10 levels compared with unstimulated or live P. gingivalis-stimulated cells from both healthy individuals or those with CP. Overall, PBMCs from patients with CP produced significantly lower IL-10 in response to ConA and P. gingivalis, suggesting chronic suppression of the anti-inflammatory cytokine production. Blocking the proinflammatory cytokine response did not result in any substantial change in IL-10 or IL-4 response to live P. gingivalis. Blocking the proinflammatory cytokine response restored IL-10 production by cells from CP in response to P. gingivalis lipopolysaccharide.

Conclusions: These findings suggest that PBMCs from patients with CP have suppressed anti-inflammatory cytokine production that can, in part, be restored by neutralizing proinflammatory cytokines. Monocytes are an important source of IL-10 production, and monocyte-derived IL-10 might play a regulatory role in the pathogenesis of CP.

PubMed Disclaimer

Conflict of interest statement

None of the authors have any conflict of interest.

Figures

Figure 1
Figure 1. IL-10 and IL-4 release by PBMCs from healthy donors
PBMC were stimulated in the presence and absence of a combination of neutralizing antibodies to the pro-inflammatory cytokines TNF-α, IL-1α, and IL-1β [0.25µg/ml (anti-TNF-α), 0.31µg/ml (anti-IL-1α), and 0.031µg/ml (anti-IL-1β)]. Each experiment was repeated in duplicate; results represent mean and standard deviations. Panels A and B: A specific T cell-activator (ConA; 500µg/ml) significantly increased cytokine release compared to unstimulated (resting) cells (*p<0.05). Blocking pro-inflammatory cytokine release did not significantly change the ConA-induced IL-10 and IL-4 release by healthy cells (p>0.05). Panels C and D: Live P. gingivalis did not significantly induce IL-10 or IL-4 production by the PBMC (p>0.05); heat-killed P. gingivalis led to a significant increase in IL-10 levels compared to unstimulated (*p<0.05) or live P. gingivalis-stimulated cells (#p<0.05). Blocking pro-inflammatory cytokine response did not result in any substantial change in IL-10 or IL-4 response (p>0.05). Panels E and F: P. gingivalis LPS (100ng/ml) induced a significant increase in IL-10 (*p<0.05) with no impact on IL-4 levels (p>0.05). E. coli LPS (100ng/ml) induced significant IL-10 production (*p<0.05) with no substantial change in IL-4 levels (p>0.05).
Figure 2
Figure 2. IL-10 and IL-4 release by PBMC from patients with chronic periodontitis
PBMC were stimulated in the presence and absence of a combination of neutralizing antibodies to the pro-inflammatory cytokines TNF-α, IL-1α, and IL-1β [0.25µg/ml (anti-TNF-α), 0.31µg/ml (anti-IL-1α), and 0.031µg/ml (anti-IL-1β)]. Each experiment was repeated in duplicate; results represent mean and standard deviations. Panels A and B: Con A (500µg/ml) stimulation did not produce significant IL-10 in PBMC from chronic periodontitis patients compared to unstimulated cells (p>0.05). The difference was significant compared to cells from healthy donors (¥p<0.05). IL-4 production was significantly increased compared to unstimulated cells (*p<0.05), while significantly less than healthy cells (¥p<0.05). Panels C and D: Live P. gingivalis did not significantly induce IL-10 or IL-4 production (p>0.05); heat-killed P. gingivalis led to a significant increase in IL-10 levels compared to unstimulated (*p<0.05) or live P. gingivalis-stimulated cells (#p<0.05). Blocking the pro-inflammatory cytokine response did not result in any substantial change in IL-10 or IL-4 response (p>0.05). IL-10 production by PBMC from periodontitis patients in response to heat-killed P. gingivalis was significantly less than the cells from healthy donors (¥p<0.05). Panels E and F: P. gingivalis LPS (100ng/ml) did not induce a significant increase in IL-10 or in IL-4 levels (p>0.05) compared to unstimulated cells. When IL-1 and TNF-α were blocked, P. gingivalis LPS-induced IL-10 production was significantly higher than unstimulated cells (*p<0.05) with no change in Il-4 release. P. gingivalis LPS-induced IL-10 production by the PBMC from periodontitis patients was significantly less than the healthy cells with or without neutralization of pro-inflammatory cytokines (¥p<0.05). E. coli (100ng/ml) LPS stimulated IL-10 by the PBMC significantly compared to resting (*p<0.05) and P. gingivalis-LPS-stimulated (#p<0.05) cells. When the TNF-α and IL-1 responses were blocked, E. coli LPS-induced IL-10 production was significantly reduced (p<0.05), significantly lower than the P. gingivalis LPS (#p<0.05) or healthy cells (¥p<0.05).
Figure 3
Figure 3. IL-10 production from monocytes in response to P. gingivalis
Each experiment was repeated in duplicate; results represent mean and standard deviations. Panels A and B: Live P. gingivalis did not generate any significant IL-10 production by the monocytes; heat-killed P. gingivalis led to a statistically significant increase in IL-10 production compared to resting (*p<0.05) or live bacteria-stimulated (#p<0.05) cells. Blocking the pro-inflammatory cytokine activity did not result any significant change compared to cells that were not exposed to neutralization, while statistically significant compared to resting (*p<0.05) or live- bacteria-stimulated (#p<0.05) cells with neutralization. Panels C and D: LPS (100ng/ml) from both E. coli and P. gingivalis caused significant IL-10 production from monocytes compared to resting cells (*p<0.05). Blocking pro-inflammatory cytokines did not lead to any significant change in IL-10 production in response to E. coli LPS (p>0.05), while there was a significant increase in IL-10 response to LPS from P. gingivalis after 48 hours of neutralization (p<0.05). At both 24 and 48 hours, P. gingivalis LPS-stimulated IL-10 production by the monocytes was significantly higher than the E. coli LPS-treated cells under neutralization (#p<0.05).

Similar articles

Cited by

References

    1. Grenier D, La VD. Proteases of Porphyromonas gingivalis as important virulence factors in periodontal disease and potential targets for plant-derived compounds: a review article. Curr Drug Targets. 2011;12:322–331. - PubMed
    1. Lin L, Li C, Liu J, et al. Virulence genes of Porphyromonas gingivalis W83 in chronic periodontitis. Acta Odontol Scand. 2009;67:258–264. - PubMed
    1. Huang PA, Roth GA, Cheng B, et al. Enhanced monocyte migration and pro-inflammatory cytokine production by Porphyromonas gingivalis infection. J Periodont Res. 2010;45:239–245. - PubMed
    1. Wang PL, Ohura K. 2002. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and toll-like receptors. Crit Rev Oral Med. 2002;13:132–142. - PubMed
    1. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontology 2000. 1997;14:33–53. - PubMed

Publication types

MeSH terms